Fundraising Fox

IRWD

Cambridge, US · Delaware corporation · 5 known investors

ironwoodpharma.com ↗
Biotechin /ironwood-pharmaceuticals@ironwoodpharma

Founders & leadership

LS
LAWRENCE S. OLANOFFDirector
TG
TERRANCE G. MCGUIREDirector
MG
MARK G. CURRIEExecutive Officer
EP
EDWARD P. OWENSDirector
JM
JULIE MCHUGHDirector
HE
HALLEY E. GIBLERTExecutive Officer
PM
PETER M. HECHTExecutive Officer, Director
MH
MARSHA H. FANUCCIDirector
TG
THOMAS GRANEYExecutive Officer
DE
DOUGLAS E. WILLIAMSDirector
CT
CHRISTOPHER T. WALSHDirector
TA
THOMAS A. MCCOURTExecutive Officer

Investors · 5

F-Prime Capital PartnersCambridge · $3M – $10M
Mountain Group CapitalNashville
Ridgeback CapitalMiami
Maverick VenturesreportedSan Francisco · $3M – $10M
Polaris PartnersreportedBoston · $500K – $5M

Reported raises · per SEC filings

Form D private placements
▶$150MraisedOct 2016 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • LAWRENCE S. OLANOFFDirector
  • TERRANCE G. MCGUIREDirector
  • MARK G. CURRIEExecutive Officer
  • EDWARD P. OWENSDirector
  • JULIE MCHUGHDirector
  • HALLEY E. GIBLERTExecutive Officer
  • PETER M. HECHTExecutive Officer, Director
  • MARSHA H. FANUCCIDirector
  • THOMAS GRANEYExecutive Officer
  • DOUGLAS E. WILLIAMSDirector
  • CHRISTOPHER T. WALSHDirector
  • THOMAS A. MCCOURTExecutive Officer
  • ANDREW DREYFUSDirector
Offering amount
$150M
Amount sold
$150M
Sales commissions
$20K
Finders' fees
$20K
Placement agents
J. WOOD CAPITAL ADVISORS
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.